Found 7 matching trials
Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease
PHASE1Safety study of AADC gene transfer (VY-AADC01) in subjects with Parkinson's...
Location
University of California, San Francisco
A Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion
PHASE2This clinical trial expansion is to offer patients, who are not enrolled in...
Location
National Taiwan University Hospital
AAV2-hAADC for Parkinson's Disease (PDCS-01)
PHASE1This study is looking at whether a gene therapy called AAV2-hAADC is safe a...
Location
The Ohio State University
A Phase I/II Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC
PHASE1This Phase I/II trial is to prove the efficacy and safety of AAV2-hAADC to ...
Location
National Taiwan University Hospital
VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)
PHASE1The objective of this study is to assess the safety of VY-AADC02 in partici...
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
PHASE1The overall objective of this study is to determine the safety and efficacy...
Location
University of California San Francisco, Benioff Children's Hospital
Observational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies
N/AAn extension study for participants who have completed a prior VY-AADC01 cl...
Location
University of California, San Francisco